Stay informed with product updates, company news, and industry insights.
Mr. McAdam will be responsible for overseeing the global finance and information technology functions.
Sapphiros, a leading consumer diagnostics company, has launched its new direct-to-consumer wellness brand, NowFuture™.
Sapphiros announced continuation of support from the Rapid Acceleration of Diagnostics (RADx®) program to support the development of a molecular respiratory at-home diagnostic
Sapphiros, a platform company dedicated to building the next generation of consumer diagnostic technologies, is proud to announce it has entered into a distribution agreement with Cencora, Inc., formerly AmerisourceBergen Corporation.
Satio is pleased to announce a $3.5 million Small Business Innovation Research (SBIR) contract awarded by the Advanced Research Projects Agency for Health (ARPA-H), National Institutes of Health, Department of Health and Human Services.
Satio is pleased to announce a contract awarded by the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response within the U.S. Department of Health and Human Services to develop a novel, single-use, rapid ebolavirus diagnostic.
Sapphiros, a platform dedicated to building the next generation of consumer diagnostics, is pleased to announce the appointment of Andrew Garfield as its new Vice President of Operations.
GrapheneDxTM, General Graphene Corporation and SapphirosTM announce a strategic partnership to industrialize graphene-based biosensors for medical devices used to diagnose a variety of diseases at the point-of-care and in consumer settings.
Sapphiros has been selected by the National Institutes of Health (NIH) to develop a high performance, over-the-counter, molecular multiplex respiratory diagnostic test that can rapidly detect RSV, influenza A, influenza B and COVID-19.
For media inquiries, contact Becky Slack by emailing becky.slack@your-agenda.com or calling +44 7854 221568.
